Benralizumab for treating relapsing or refractory eosinophilic granulomatosis with polyangiitis [ID6266]

  • In development
  • GID-TA11248
  • Expected publication date: TBC

Documents

Documents created during the development process.

Declaration of interests

Invitation to participate

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6266